Back

Sacubitril/valsartan and prevention of chemotherapy-induced cardiac dysfunction: meta-analysis of randomized trials

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Protection and safety in cardio‑oncology Cardiotoxicity of Drugs ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Caroline Fischer Bacca

University Center for the Development of Alto Vale - UNIDAVI, Rio do Sul (Brazil)

5 More presentations in this session

Presentation thumbnail
Pleiotropic effects of canagliflozin and dapagliflozin in cadio-oncology: a novel strategy to balance antitumor efficacy and cardiotoxicity in HER2-positive breast cancer therapy
Doctor N. Maurea (Naples, IT)
Abstract
Presentation thumbnail
Adverse cardiovascular events associated with kinase inhibitors and the prognostic value of imaging – a single-center retrospective cohort study in cancer patients
Mr J. Singh (US)
Abstract
Presentation thumbnail
Febuxostat exacerbates doxorubicin-induced cardiac remodelling in a murine model of cardiomyopathy
Doctor S. Jezsoviczky (Budapest, HU)
Abstract
Presentation thumbnail
Genetic susceptibility to early anthracycline cardiotoxicity: the role of CBR3 polymorphisms
Miss A. Rozhanskiy (Sao Paulo, BR)
Abstract
Presentation thumbnail
Dynamic circulating microRNA signatures associated with cancer therapy-related cardiotoxicity in breast cancer patients
Doctor E. Oikonomou (Athens, GR)
Abstract

Access the full session

Session thumbnail
Protection and safety in cardio‑oncology

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Sacubitril/Valsartan and cardiovascular outcomes in cancer patients on anthracycline therapy: a global health research network retrospective analysis
20 June 2025
thumbnail
Congress Presentation
Right ventricular strain as a predictor of trastuzumab-induced chemotherapy-related cardiac dysfunction: a meta-analysis
11 December 2024
thumbnail
Congress Presentation
Does the short-term cardioprotection prevent diastolic dysfunction?
21 June 2025
thumbnail
Congress Presentation
Effects of sacubitril valsartan on renal function in adults with heart failure: a systematic review and meta analysis of randomised controlled trials
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources